Treatment of Temporomandibular Joint Osteoarthritis by Viscosupplement. Satisfaction Predictive Factors

Launched by LABRHA · Aug 10, 2018

Keywords

ClinConnect Summary

Forty patients presenting an ATM asserted by radiography and justifying a viscosupplement, without other selection criterion than the opinion of the investigator concerning the legitimacy of a viscosupplement and the agreement of the patient participating in the study.

The data collected during the consultations at J0, J90 and J180 will be inputed by the investigator in the paper version of the CRF.

The informations collected during the initial consultation (J0) are: demographic (sex, age, weight, size), pathological (history of the disease, target side, previous treatments, evaluation of...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients of both genders, of all ages
• • Hallux rigidus confirmed by radiography including frontal and side radiographies performed during the last 12 months
• • Patients requiring a viscosupplement based on the opinion of the investigator
• • Patients were able to read and understand the information sheet, to give their enlighted consent and to respect follow up consultations
• Exclusion Criteria:
• • Patient with hypersensitivity to hyaluronic acid or mannitol
• • Patient with a contraindication to the injection procedure : infected skin lesions on or close to an injection site, infectious disease ongoing
• • Patient who received a viscosuplement during the last 6 months
• • Patient who received an intra-articular injection of corticoids in the target articulation during the last 3 month before the inclusion
• • Patient not talking french